IR vs PH vs EMR Stock Comparison

Ingersoll Rand, Parker-Hannifin and Emerson Electric Prices as of Oct 26, 2026 Peers: Industry group
IR Ingersoll Rand Inc.
$74.54 -2.0% 1M -6.6% 1Y
Market cap
$29.49B
P/E
30.7x
Revenue (TTM)
$7.94B
Div. yield
0.00%
Pumps and Valves Industrials
3 wins
PH Parker-Hannifin Corp
$904.18 -7.6% 1M +17.1% 1Y
Market cap
$113.87B
P/E
31.2x
Revenue (TTM)
$21.50B
Div. yield
–
Pumps and Valves Industrials
7 wins
EMR Emerson Electric Co
$161.75 +2.3% 1M +21.9% 1Y
Market cap
$92.93B
P/E
36.0x
Revenue (TTM)
$18.64B
Div. yield
0.01%
Pumps and Valves Industrials
2 wins

Head to Head

12 decided of 12

Parker-Hannifin leads on 7 of the 12 questions below (Parker-Hannifin 7, Ingersoll Rand 3, Emerson Electric 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionIRPHEMRLeader
Larger companyMarket capitalisation $29.49B $113.87B $92.93B PH
Cheaper on earningsLower P/E, profitable companies only 30.7x 31.2x 36.0x IR
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.3x 23.8x 24.0x IR
Faster revenue growthRevenue growth, trailing twelve months +7.8% +8.3% +4.8% PH
More profitableNet margin, trailing twelve months 12.1% 17.0% 13.8% PH
Better return on capitalReturn on invested capital 7.6% 15.4% 10.9% PH
Less leveragedLower net debt / EBITDA 1.8x 1.4x 1.8x PH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% EMR
Better 1-year returnPrice return, last 12 months -6.6% +17.1% +21.9% EMR
Better 5-year returnAnnualised price return, 5 years +7.0%/yr +24.9%/yr +11.0%/yr PH
Less volatileAnnualised volatility, 1 year 33.1% 27.2% 31.7% PH
Higher overall scoreMean of the five percentile scores vs peers 58/100 57/100 45/100 IR

Percentile Scorecard

IRPHEMR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisIRPHEMR
Valuation 42 #118 of 203 25 #152 of 203 35 #133 of 203
Growth 71 #55 of 187 69 #59 of 187 40 #112 of 187
Profitability 72 #53 of 185 94 #12 of 185 85 #29 of 185
Financial Health 50 #110 of 219 44 #123 of 219 29 #155 of 219
Shareholder Returns 55 #69 of 153 51 #76 of 153 36 #98 of 153
Overall 58 57 45
  • IR ranked among 222 companies in Machinery
  • PH ranked among 222 companies in Machinery
  • EMR ranked among 222 companies in Machinery

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodIRPHEMRSPY
1 month -2.0%-7.6%+2.3% -0.8%
3 months -11.9%-8.4%+8.3% +3.5%
6 months -11.3%-7.2%+14.3% +7.0%
Year to date -5.9%+2.9%+21.9% +12.2%
1 year -6.6%+17.1%+21.9% +13.0%
3 years +25.5%+146.9%+83.7% +86.3%
3 years, per year +7.9%+35.2%+22.5% +23.1%
5 years +40.1%+203.4%+68.2% +68.6%
5 years, per year +7.0%+24.9%+11.0% +11.0%
10 years —+642.1%+220.7% +258.0%
10 years, per year —+22.2%+12.4% +13.6%

Risk

MeasureIRPHEMRSPY
Volatility, 1Y 33.1%27.2%31.7% 12.7%
Downside volatility, 1Y 31.5%26.9%33.5% 12.7%
Beta vs S&P 500, 1Y 1.230.841.53 1.00
Return / volatility, 1Y -0.200.630.69 1.02
Max drawdown, 5Y -36.6%-29.2%-29.9% -25.4%
From 52-week high -24.5%-15.8%-1.6% -1.8%
52-week high $98.76$1,073.86$164.37 $779.14
52-week low $68.54$767.01$123.30 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleIRPHEMR
P/E now vs peer median 30.3xmedian 26.0x 31.3xmedian 26.0x 35.1xmedian 26.0x
P/S now vs peer median 3.6xmedian 1.9x 5.3xmedian 1.9x 4.8xmedian 1.9x
EV/EBITDA now vs peer median 16.5xmedian 14.0x 21.9xmedian 14.0x 16.4xmedian 14.0x
P/FCF now vs peer median 23.7xmedian 21.4x 29.2xmedian 21.4x 26.1xmedian 21.4x
P/B now vs peer median 2.8xmedian 2.2x 7.4xmedian 2.2x 4.4xmedian 2.2x
PEG now vs peer median 2.44median 1.26 1.49median 1.26 -0.84median 1.26

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsIRPHEMR
Revenue $7.94B $21.50B $18.64B
Gross profit $3.40B $8.10B $9.91B
Operating income $1.44B $4.63B $4.68B
Net income $966.00M $3.65B $2.58B
Free cash flow $1.22B $3.91B $3.46B
EPS (diluted) $2.45 $28.48 $4.59
Cash & equivalents $1.17B $501.00M $2.18B
Total debt $4.77B $8.52B $13.11B
Shares (diluted) 391.90M 128.10M 561.10M
Enterprise value $24.62B $111.99B $85.67B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricIRPHEMR
P/E 30.3x 31.3x 35.1x
P/FCF 23.7x 29.2x 26.1x
P/Operating cash flow 21.4x 26.1x 23.1x
P/S 3.6x 5.3x 4.8x
P/B 2.8x 7.4x 4.4x
P/Tangible book 4.7x 14.0x 7.7x
EV/EBITDA 16.5x 21.9x 16.4x
EV/EBIT 22.6x 26.3x 21.6x
EV/Revenue 4.1x 5.7x 5.4x
EV/FCF 26.7x 31.2x 29.2x
EV/Operating cash flow 24.1x 28.0x 25.8x
PEG (3Y EPS CAGR) 2.44 1.49 -0.84

Growth

14 metrics
MetricIRPHEMR
Revenue growth (1Y) 7.8% 8.3% 4.8%
Revenue CAGR (3Y) 7.2% 4.1% 7.6%
Gross profit growth (1Y) 5.6% 10.8% 5.7%
Gross profit CAGR (3Y) 9.5% 8.0% 11.0%
Operating income growth (1Y) 28.9% 14.1% 9.2%
Operating income CAGR (3Y) 13.7% 14.6% 13.6%
Net income growth (1Y) 82.8% 3.3% -3.0%
Net income CAGR (3Y) 10.9% 20.5% -42.0%
EPS growth (1Y) 87.6% 5.0% -2.2%
EPS CAGR (3Y) 12.4% 21.1% -41.6%
Operating cash flow growth (1Y) -5.8% 15.6% 4.4%
Operating cash flow CAGR (3Y) 9.5% 13.6% 10.1%
Free cash flow growth (1Y) -6.1% 16.9% 4.4%
Free cash flow CAGR (3Y) 9.6% 14.5% 9.4%

Profitability

14 metrics
MetricIRPHEMR
Gross margin 42.8% 37.7% 53.2%
EBITDA margin 24.8% 25.9% 33.1%
Operating margin 18.1% 21.6% 25.1%
Pretax margin 15.2% 21.2% 17.6%
Net margin 12.1% 17.0% 13.8%
FCF margin 15.4% 18.2% 18.6%
Operating cash flow margin 17.0% 20.3% 21.0%
Return on equity 9.4% 24.3% 12.7%
Return on assets 5.3% 11.9% 6.1%
Return on invested capital 7.6% 15.4% 10.9%
Return on capital employed 9.2% 18.8% 14.9%
Asset turnover 0.4x 0.7x 0.4x
Cash conversion (OCF / net income) 1.4x 1.2x 1.5x
Stock comp / revenue 0.7% 0.8% 1.3%

Financial Health

11 metrics
MetricIRPHEMR
Debt / assets 26.2% 27.6% 31.1%
Debt / equity 0.5x 0.6x 0.6x
Net debt / EBITDA 1.8x 1.4x 1.8x
Debt / FCF 3.9x 2.2x 3.8x
Liabilities / assets 43.7% 50.1% 51.7%
Equity / assets 56.3% 49.9% 48.3%
Interest coverage 5.6x 11.6x –
Current ratio 1.6x 1.3x 0.9x
Quick ratio 1.0x 0.6x 0.5x
Cash ratio 0.4x 0.1x 0.2x
Altman Z-score 3.26 6.79 4.64

Shareholder Returns

7 metrics
MetricIRPHEMR
Dividend yield 0.1% 0.8% 1.4%
Net buyback yield 2.8% 1.1% 1.0%
Shareholder yield 3.0% 1.9% 2.4%
Payout ratio (earnings) 3.3% – 47.8%
Payout ratio (FCF) 2.6% – 35.6%
Dividend growth (1Y) -2.8% – 3.1%
Dividend CAGR (3Y) -1.0% – 0.7%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusIRPHEMR
Forward P/E 22.3xFY2026 23.8xFY2027 24.0xFY2026
EPS, next fiscal year $3.35FY2026 $37.94FY2027 $6.75FY2026
EPS growth, next FY +0.3%FY2026 +17.4%FY2027 +12.5%FY2026
EPS growth, the year after +21.5% +8.8% +15.3%
Revenue, next fiscal year $8.35BFY2026 $23.49BFY2027 $18.13BFY2026
Revenue growth, next FY +9.2%FY2026 +9.2%FY2027 +0.6%FY2026
Revenue growth, the year after +6.4% +22.0% +15.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersIRPHEMR
Held by institutions 100.0% 91.8% 82.1%
Institutions holding 894 1,975 2,290
Change in shares held, QoQ -1.5% +1.2% +0.9%
Institutions buying 367 927 1,080
Institutions selling 360 693 798
Buyers to sellers 1.02 1.34 1.35

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

IRPHEMR
IR 1.00 0.61 0.69
PH 0.61 1.00 0.54
EMR 0.69 0.54 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, IR, PH and EMR?

Parker-Hannifin (PH) is the largest by market capitalisation: Ingersoll Rand (IR) $29.49B, Parker-Hannifin (PH) $113.87B, Emerson Electric (EMR) $92.93B.

Which stock is cheaper, IR, PH and EMR?

Ingersoll Rand (IR) trades on the lowest price-to-earnings ratio (Ingersoll Rand (IR) 30.7x, Parker-Hannifin (PH) 31.2x, Emerson Electric (EMR) 36.0x). On next year's consensus earnings, Ingersoll Rand (IR) is cheapest (Ingersoll Rand (IR) 22.3x, Parker-Hannifin (PH) 23.8x, Emerson Electric (EMR) 24.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Parker-Hannifin (PH) grew revenue fastest over the trailing twelve months: Ingersoll Rand (IR) +7.8%, Parker-Hannifin (PH) +8.3%, Emerson Electric (EMR) +4.8%.

Which company is more profitable?

Parker-Hannifin (PH) has the highest net margin (Ingersoll Rand (IR) 12.1%, Parker-Hannifin (PH) 17.0%, Emerson Electric (EMR) 13.8%). On return on invested capital, Parker-Hannifin (PH) leads (Ingersoll Rand (IR) 7.6%, Parker-Hannifin (PH) 15.4%, Emerson Electric (EMR) 10.9%).

Which stock has performed better?

Over the past year Emerson Electric (EMR) returned the most: Ingersoll Rand (IR) -6.6%, Parker-Hannifin (PH) +17.1%, Emerson Electric (EMR) +21.9%. Over five years, Parker-Hannifin (PH) compounded fastest (Ingersoll Rand (IR) +7.0%/yr, Parker-Hannifin (PH) +24.9%/yr, Emerson Electric (EMR) +11.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Emerson Electric (EMR) has the highest dividend yield: Ingersoll Rand (IR) 0.00%, Parker-Hannifin (PH) 0.00%, Emerson Electric (EMR) 0.01%. Parker-Hannifin (PH) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Parker-Hannifin (PH) has been the steadiest (Ingersoll Rand (IR) 33.1%, Parker-Hannifin (PH) 27.2%, Emerson Electric (EMR) 31.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, IR, PH and EMR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Parker-Hannifin (PH) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.